Holzer & Holzer, LLC informs investors that a class action lawsuit was filed against Kiromic BioPharma, Inc. (“Kiromic” or the “Company”) (NASDAQ: KRPB). The lawsuit alleges Kiromic failed to disclose that the FDA imposed a clinical hold for two of its new drug candidates prior to the filing of the Registration Statement and Prospectus, contrary to assurances the Company made to investors. If you bought shares of Kiromic between June 25, 2021 and August 13, 2021, and you suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey Holzer, Esq. at firstname.lastname@example.org or Joshua Karr, Esq. at email@example.com, by toll-free telephone at (888) 508-6832 or you may visit the firm’s website at www.holzerlaw.com to learn more. The deadline to ask the court to be appointed lead plaintiff in the case is October 4, 2022.
Lead Plaintiff Deadline Has Passed
October 4, 2022